ATE400281T1 - Vaginales lactobacillus-medikament - Google Patents

Vaginales lactobacillus-medikament

Info

Publication number
ATE400281T1
ATE400281T1 AT98920842T AT98920842T ATE400281T1 AT E400281 T1 ATE400281 T1 AT E400281T1 AT 98920842 T AT98920842 T AT 98920842T AT 98920842 T AT98920842 T AT 98920842T AT E400281 T1 ATE400281 T1 AT E400281T1
Authority
AT
Austria
Prior art keywords
medication
vaginal
disclosed
medicant
vaginal lactobacillus
Prior art date
Application number
AT98920842T
Other languages
English (en)
Inventor
Gerald Chrisope
Original Assignee
Osel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osel Inc filed Critical Osel Inc
Application granted granted Critical
Publication of ATE400281T1 publication Critical patent/ATE400281T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AT98920842T 1997-04-11 1998-04-10 Vaginales lactobacillus-medikament ATE400281T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/834,649 US6093394A (en) 1997-04-11 1997-04-11 Vaginal lactobacillus medicant

Publications (1)

Publication Number Publication Date
ATE400281T1 true ATE400281T1 (de) 2008-07-15

Family

ID=25267456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920842T ATE400281T1 (de) 1997-04-11 1998-04-10 Vaginales lactobacillus-medikament

Country Status (12)

Country Link
US (3) US6093394A (de)
EP (1) EP1011721B1 (de)
JP (2) JP2001523231A (de)
KR (1) KR20010006273A (de)
CN (1) CN1194758C (de)
AT (1) ATE400281T1 (de)
AU (1) AU732630B2 (de)
BR (1) BR9808520A (de)
CA (1) CA2285947C (de)
DE (1) DE69839699D1 (de)
NZ (2) NZ513835A (de)
WO (1) WO1998046261A1 (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
GB9916790D0 (en) * 1999-07-16 1999-09-22 Health Lab Service Board Storage of microorganisms,cells and tissue
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US7179458B2 (en) * 2002-03-08 2007-02-20 Osel, Inc. Lactobacilli expressing biologically active polypeptides and uses thereof
PL212647B1 (pl) * 2002-03-21 2012-11-30 Bifodan As Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
KR100993562B1 (ko) 2002-03-21 2010-11-11 비포단 에이/에스 락토바실러스 균주
US7829079B2 (en) * 2002-03-28 2010-11-09 Christian Hansen A/S Lactobacillus iners for the enhancement of urogenital health
JP2004067599A (ja) * 2002-08-07 2004-03-04 Kunihiko Tominaga 腟内洗浄剤
AT413334B (de) * 2002-12-23 2006-02-15 Belihart Josephine Feste darreichungsformen mit lebenden milchsäurebakterien
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
US20050095660A1 (en) * 2003-10-31 2005-05-05 Unibio, S.R.I. Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women
DK1506781T3 (da) * 2003-11-03 2005-06-13 Peter-Hansen Volkmann Vaginalplejesammensætning
GB2408750B (en) * 2003-12-02 2008-12-10 Arthur A Codd Preservation of biological material
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
EP1781344A4 (de) * 2004-07-23 2009-06-17 Femaceuticals Llc Minipolster zur verringerung von entzündung der vulva und herstellungsverfahren dafür
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
WO2006045474A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
US20060217446A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating trichomonas vaginitis
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) * 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
EP1919446A4 (de) * 2005-08-04 2009-01-14 Femaceuticals Llc Verfahren zur behandlung von hautirritationen wie z. b. windelausschlag
US20070082035A1 (en) 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
EP1965839B1 (de) 2005-12-22 2012-07-25 SCA Hygiene Products AB Saugfähiger artikel
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
CN101557838A (zh) * 2006-11-17 2009-10-14 Sca卫生用品公司 包含微生物抑制性组合物的卫生织物
JP5112444B2 (ja) 2006-11-17 2013-01-09 エスセーアー・ハイジーン・プロダクツ・アーベー カンジダ症及び尿路感染の予防及び／または治療のための発酵乳酸桿菌Ｅｓｓ−１、ＤＳＭ１７８５１及びそれの使用
CN109010899A (zh) 2006-11-17 2018-12-18 Sca卫生用品公司 包含微生物抑制性组合物的卫生用品
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
WO2009079607A1 (en) * 2007-12-18 2009-06-25 Osel, Inc. Applicator for applying powder formulations and uses thereof
US8642029B2 (en) 2008-03-31 2014-02-04 Osel, Inc. Transiently buffered Lactobacillus preparations and use thereof
ITMI20080949A1 (it) * 2008-05-22 2009-11-23 Sinclair Pharma Srl Nuovo ceppo del genere lactobacillus e formulazioni farmaceutiche topiche che lo contengono
EP2206506A1 (de) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotische Formulierungen
US7888062B1 (en) 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US8445226B2 (en) 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
IL208820A0 (en) 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
TWI401086B (zh) * 2010-07-20 2013-07-11 Univ China Medical 胚芽乳酸桿菌及其用途
US9034593B2 (en) 2010-11-22 2015-05-19 Kimberly-Clark Worldwide, Inc. Vaginal indicator to detect biomarkers of good health
CZ2010933A3 (cs) * 2010-12-15 2011-08-31 Valosun A.S. Probiotické kmeny Lactobacillus fermentum 16A/1 a Lactobacillus crispatus 13A a jejich využití k vaginální aplikaci
CN103958664A (zh) * 2011-11-10 2014-07-30 通用工厂公司 用于提高杆状细菌的生存力的手段和方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
EP2809301A1 (de) * 2012-01-31 2014-12-10 Biosoma B.V. Verfahren zur verabreichung eines probiotikums
CN110693812A (zh) 2012-06-13 2020-01-17 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CN102716325A (zh) * 2012-06-28 2012-10-10 刘倩 一种治疗慢性盆腔炎的中药制剂
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
FR2992973B1 (fr) 2012-07-09 2015-12-18 S P M D Nouvelle souche de lactobacillus crispatus
CN103074270A (zh) * 2012-11-15 2013-05-01 上海交大昂立股份有限公司 一种卷曲乳杆菌及其应用
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN103911308A (zh) * 2013-01-05 2014-07-09 欣力菲生物医药技术（天津）有限公司 卷曲乳杆菌菌株及其用途
CN104178437B (zh) * 2013-11-08 2016-08-24 苏州欧赛微科生物医药科技有限公司 一种卷曲乳杆菌及其在妇科疾病中的应用
KR101808972B1 (ko) * 2013-11-08 2017-12-13 쑤저우 오셀 바이오-팜 컴퍼니 리미티드 락토바실러스 크리스파투스 및 이의 사용
NZ722215A (en) 2013-12-19 2019-02-22 Evofem Inc Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
CN104293718B (zh) * 2014-10-11 2017-01-18 中国科学院微生物研究所 一株詹氏乳杆菌及其应用
KR101980252B1 (ko) 2015-05-26 2019-05-21 (주)투라인스 질증 치료용 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
MX387286B (es) 2015-09-29 2025-03-18 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
FR3048361B1 (fr) * 2016-03-01 2020-12-18 Biose Compositions pour le traitement des candidoses
KR101957211B1 (ko) * 2016-03-21 2019-03-13 한국생명공학연구원 조산 및 질염 원인균에 대한 항균 활성, 성병 원인 바이러스에 대한 항바이러스 활성 및 질내 부착능이 우수한 락토바실러스 속 균주 및 이의 용도
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
AU2017296016A1 (en) * 2016-07-11 2019-01-24 Hennepin Life Sciences, Llc Compositions for sexually transmitted diseases
CN106176821A (zh) * 2016-08-31 2016-12-07 汪金小 一种微生态阴道菌剂及其制备方法和应用
EP3512532A1 (de) 2016-09-16 2019-07-24 DuPont Nutrition Biosciences ApS Bakterien
CN110225750A (zh) 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法
CN110799198A (zh) * 2016-11-30 2020-02-14 普罗生物瑞士股份公司 用于稳定阴道液的酸度和氧化还原状态的基于合适的生化组合物的泌尿生殖器医疗设备制剂
KR102048690B1 (ko) * 2016-12-16 2019-11-26 (주)휴온스 안정성이 증진된 유산균 및 이의 제조방법
BR112019015239A2 (pt) 2017-02-28 2020-04-14 Kimberly Clark Co composição, e, método para manter um equilíbrio de microflora saudável na área urogenital de um paciente com necessidade do mesmo.
US11384358B2 (en) 2017-03-29 2022-07-12 President And Fellows Of Harvard College Method of regulating gene expression in a cell
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
CN107299065B (zh) * 2017-06-20 2020-02-14 广东强基药业有限公司 一种植物乳杆菌及其用于制备阴道抑菌药物的应用
WO2019010281A1 (en) * 2017-07-07 2019-01-10 Osel, Inc. USE OF VAGINAL LACTOBACILLES TO IMPROVE IN VITRO FERTILIZATION RATE OF SUCCESS
JP7347760B2 (ja) * 2017-07-07 2023-09-20 オセル、インコーポレイテッド 高効力かつ安定な膣ラクトバチルス調製物
US11530433B2 (en) 2017-10-20 2022-12-20 President And Fellows Of Harvard College Artificial secretion peptides for heterologous protein production
CN107815432B (zh) * 2017-12-07 2021-09-28 广州柏芳生物科技有限公司 一种人用灭活乳酸菌制剂及其用途
ES2980222T3 (es) 2018-08-30 2024-09-30 Osel Inc Bacteriocinas para mejorar la colonización vaginal de Lactobacillus productor de peróxido de hidrógeno para la salud de reproducción femenina
GB201816425D0 (en) * 2018-10-09 2018-11-28 Tervisetehnoloogiate Arenduskeskus As Probiotics
KR102053744B1 (ko) * 2018-11-27 2019-12-09 한국생명공학연구원 질염 원인균에 대한 항균 활성 및 질내 부착능이 우수한 락토바실러스 속 균주 및 이의 용도
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP4294417A1 (de) * 2021-02-19 2023-12-27 Imperial College Innovations Limited Lactobacillus crispatus-zusammensetzung zur verwendung bei schwangeren personen
KR20230059753A (ko) * 2021-10-26 2023-05-03 일동제약(주) 락토바실러스 크리스파투스 균주 및 이를 포함하는 질염의 예방 또는 치료용 조성물
KR102683248B1 (ko) 2021-11-10 2024-07-10 장효영 질염 예방 및 치료를 위한 주입형 질 유산균 조성물
CN115337256A (zh) * 2022-06-24 2022-11-15 郑州伊品医药科技有限公司 一种含有益生菌的阴道栓塞及胶囊的制备方法
CN116355805B (zh) * 2023-04-11 2025-07-25 吉林大学 一株猪源广谱抑菌的阴道乳杆菌及其应用
CN118308277B (zh) * 2024-06-12 2024-09-13 广州莱可福生物科技有限公司 一种卷曲乳杆菌及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127268A (de) * 1970-01-12 1900-01-01
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
JPS5953425A (ja) * 1982-09-22 1984-03-28 Meiji Milk Prod Co Ltd 「ちつ」
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4592748A (en) * 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4956177A (en) * 1985-11-04 1990-09-11 Microlife Technics, Inc. Method for inhibiting fungi
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
SU1364341A1 (ru) * 1986-09-18 1988-01-07 Центральный научно-исследовательский институт вакцин и сывороток им.И.И.Мечникова Способ получени бифидумбактерина
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
US4765978A (en) * 1986-12-16 1988-08-23 Schering Corporation Novel vaginal suppository
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
US5296221A (en) * 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
JPH0421633A (ja) * 1990-05-17 1992-01-24 Saikon Medics:Kk 生体下口腔内有用微生物叢の維持管理法および維持管理組成物
JP3014148B2 (ja) * 1991-01-17 2000-02-28 株式会社ヤクルト本社 悪性腫瘍再発抑制剤
US5573765A (en) * 1991-02-19 1996-11-12 Mark S. Reinhard Composition and method for treatment of vaginal yeast infections
DE4109036C1 (de) * 1991-03-15 1992-08-13 Eckhard Dr. 1000 Berlin De Lauer
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
UA39965C2 (uk) * 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
FR2746109B1 (fr) * 1996-03-12 1998-04-17 Rhone Poulenc Rorer Sa Milieu pour la conservation de materiel biologique
ATE281150T1 (de) * 1996-09-13 2004-11-15 Univ Clemson Mittel zur akne behandlung
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
DE69802260T2 (de) 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen

Also Published As

Publication number Publication date
US6372209B1 (en) 2002-04-16
EP1011721A4 (de) 2003-09-24
US20020090365A1 (en) 2002-07-11
WO1998046261A1 (en) 1998-10-22
US6093394A (en) 2000-07-25
AU732630B2 (en) 2001-04-26
CN1194758C (zh) 2005-03-30
NZ500788A (en) 2003-04-29
NZ513835A (en) 2001-09-28
AU7359098A (en) 1998-11-11
EP1011721B1 (de) 2008-07-09
CA2285947A1 (en) 1998-10-22
CA2285947C (en) 2012-02-28
JP2010031031A (ja) 2010-02-12
CN1259874A (zh) 2000-07-12
BR9808520A (pt) 2002-01-15
US6468526B2 (en) 2002-10-22
DE69839699D1 (de) 2008-08-21
EP1011721A1 (de) 2000-06-28
JP2001523231A (ja) 2001-11-20
KR20010006273A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
ATE400281T1 (de) Vaginales lactobacillus-medikament
DK0506817T3 (da) Farmaceutisk præparat til kontrol med patogene intestinale bakterier
GB9822440D0 (en) Medicaments
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
SE9702083L (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
WO2002005829A3 (en) Methods and formultations with probiotic microorganisms and medicaments
IL137093A0 (en) Methods of inactivating bacteria including bacterial spores
NZ335521A (en) Bacillus thuringiensis strain AQ52 for controlling antimicrobial activity against fungi and bacteria
ES2165139T3 (es) Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
AU1223099A (en) Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
GB8701234D0 (en) Strain of microorganism
NO964359D0 (no) Sammensetning og fremgangsmåte for bekjempelse av plantesykdommer
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
PL340370A1 (en) Pesticide against pathogenic micro-organism attacking plants
AU4104397A (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
BR0009663A (pt) Composições de vacinas antibacterianas
EP1060745A3 (de) Zusammensetzung und Methode zur Behandlung von bakteriellen Infektionen
WO2003009859A1 (en) Immunotherapy for humans
AU1665900A (en) Foulbrood treatments
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
ES2067520T3 (es) Antibioticos y procedimiento para su produccion.
IT1316985B1 (it) Terreno di coltura per la coltura di lactobacillus clearans e metodoper la conservazione di detto ceppo batterico.
ATE333875T1 (de) Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties